HLA dosage effect in narcolepsy with cataplexy. (Q48026022)

7 February 2018

title

HLA dosage effect in narcolepsy with cataplexy. (English)

1 reference

7 February 2018

0 references

5

Gert J Lammers

1 reference

7 February 2018

author name string

Astrid van der Heide

1

1 reference

7 February 2018

Willem Verduijn

2

1 reference

7 February 2018

Geert W Haasnoot

3

1 reference

7 February 2018

Jos J M Drabbels

4

1 reference

7 February 2018

Frans H J Claas

6

1 reference

7 February 2018

language of work or name

English

0 references

publication date

3 October 2014

1 reference

7 February 2018

published in

Immunogenetics

1 reference

7 February 2018

volume

67

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

1-6

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00251-014-0808-z

exact match

0 references

cites work

Narcolepsy with cataplexy

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

HLA class II haplotype and sequence analysis support a role for DQ in narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

The estimation and significance of the logarithm of a ratio of frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

HLA-DQ association and allele competition in Chinese narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

DQ (rather than DR) gene marks susceptibility to narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Hypocretin (orexin) deficiency in human narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Reduced number of hypocretin neurons in human narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Invited anniversary review: HLA associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

Genetic HLA associations in complex regional pain syndrome with and without dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00251-014-0808-Z

HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

21 January 2018

1 reference

12 December 2020

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.

1 reference

12 December 2020

DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe

1 reference

12 December 2020

HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups. US Modafinil in Narcolepsy Multicenter Study Group

1 reference

12 December 2020

DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans.

1 reference

12 December 2020

T lymphocyte recognition of a celiac disease-associated cis- or trans-encoded HLA-DQ alpha/beta-heterodimer

1 reference

12 December 2020

HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.

1 reference

12 December 2020

Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant

1 reference

12 December 2020

Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes

1 reference

12 December 2020

10.1007/S00251-014-0808-Z

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

25277311

1 reference

7 February 2018